Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Amwell makes grant to new employee under inducement plan
-
Myriad Genetics Reports First Quarter 2025 Financial Results; Updates 2025 Financial Guidance
-
Comscore Reports First Quarter 2025 Results
-
Latham Group, Inc. Reports First Quarter 2025 Financial Results
-
Yelp to Participate in the J.P. Morgan 53rd Annual Global Technology, Media and Communications Conference
-
89bio to Participate in Upcoming Investor Conferences
-
Varonis Announces First Quarter 2025 Financial Results
-
Eventbrite to Participate in the J.P. Morgan Global Technology, Media and Communications Conference
-
Tandem Diabetes Care Announces Upcoming Conference Presentations
-
Pulse Biosciences To Present at the BofA Securities 2025 Health Care Conference
-
TEN Ltd. Declares Dividend on its Series E Cumulative Perpetual Preferred Shares
-
EverQuote to Present at Upcoming Investor Conferences
-
CarGurus to Present at the J.P. Morgan 53rd Annual Global Technology, Media and Communications Conference
-
Prelude Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update
-
GigaCloud Technology Inc Wins Two Gold Stevies at the 2025 American Business Awards
-
LifeMD Reports First Quarter 2025 Results and Raises Full-Year 2025 Guidance
-
Intapp Announces Third Quarter Fiscal Year 2025 Financial Results
-
First Acceptance Corporation Reports Operating Results for the Quarter Ended March 31, 2025
-
Revolve Group Announces First Quarter 2025 Financial Results
-
Lumentum Announces Fiscal Third Quarter 2025 Financial Results
-
Transcat Announces Fourth Quarter Fiscal Year 2025 Conference Call and Webcast
-
Atomera Provides First Quarter 2025 Results
-
Porch Group Reports First Quarter 2025 Results
-
Wynn Resorts, Limited Reports First Quarter 2025 Results
-
The Manitowoc Company Reports First-Quarter 2025 Financial Results; Maintains Full Year 2025 Guidance
-
WW International, Inc. Announces First Quarter 2025 Results
-
Beta Bionics Reports First Quarter 2025 Financial Results and Raises Annual Guidance for Full Year 2025
-
Unigold Announces Non-Brokered Private Placement of Up To $150,000
-
Cabral Gold Announces Closing of Upsized Financing for $14.9 Million in Proceeds
-
Vision Marine Technologies Files Patent for Advanced Software-Based Overload Protection in Electric Marine Powertrains
-
The Nike NFTs INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Nike-themed non-fungible tokens ("NFTs") Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
Crexendo Announces Strong First Quarter 2025 Results
-
NSSC INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that NAPCO Security Technologies, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
CAR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Avis Budget Group, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
ZBIO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Zenas BioPharma, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
CERE INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cerevel Therapeutics Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
VTRS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Viatris Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
SOUN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that SoundHound AI, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
MARTEN TRANSPORT DECLARES QUARTERLY DIVIDEND
-
Mercury Systems Reports Third Quarter Fiscal 2025 Results
-
Keros Therapeutics Reports Recent First Quarter 2025 Financial Results
-
AirJoule Technologies Schedules Release of First Quarter 2025 Results and Conference Call
-
Grocery Outlet Holding Corp. Announces First Quarter Fiscal 2025 Financial Results
-
CRISPR Therapeutics Provides First Quarter 2025 Financial Results and Announces Positive Top-Line Data from Phase 1 Clinical Trial of CTX310™ Targeting ANGPTL3
-
Quantum Computing Inc. to Host First Quarter 2025 Shareholder Call on Thursday, May 15, 2025
-
PTC Therapeutics Provides Corporate Update and Reports First Quarter 2025 Financial Results
-
Neurocrine Biosciences to Present at Upcoming Investor Conferences in May
-
Dynavax Reports First Quarter 2025 Financial Results and Announces New Pipeline Programs
-
Standard BioTools Reports First Quarter 2025 Financial Results
-
HALOZYME RAISES 2025 FINANCIAL GUIDANCE RANGES AND REPORTS STRONG FIRST QUARTER 2025 RESULTS


